Esperion Therapeutics | ESPR - Cash And Equivalent


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Esperion Therapeutics

Esperion Therapeutics reported $144.91M in Cash and Equivalent for its fiscal quarter ending in March of 2023.


Cash And Equivalent Change
Alnylam Pharmaceuticals ALNY:US USD 672.24M 194.15M
Amarin AMRN:US USD 191.41M 26.25M
Amgen AMGN:US USD 31.56B 22.26B
Biogen BIIB:US USD 2.9B 521.1M
BioMarin Pharmaceutical BMRN:US USD 580.07M 144.46M
Cytokinetics CYTK:US USD 765.58M 700M
Daiichi Sankyo 4568:JP JPY 441.92B 46.74B
Eli Lilly LLY:US USD 3.55B 1.48B
Esperion Therapeutics ESPR:US USD 144.91M 20.14M
Geron GERN:US USD 112.78M 55.93M
Halozyme Therapeutics HALO:US USD 96.38M 137.81M
Heron Therapeutics HRTX:US USD 27.09M 11.73M
Intercept Pharmaceuticals ICPT:US USD 61.4M 10.89M
Intra Cellular Therapies ITCI:US USD 75.73M 72.89M
Ionis Pharmaceuticals IONS:US USD 309.03M 32.56M
Minerva Neurosciences NERV:US USD 35.98M 116K
Moderna Inc MRNA:US USD 3.44B 236M
Nektar Therapeutics NKTR:US USD 76.96M 11.27M
PTC Therapeutics PTCT:US USD 167.5M 112.34M
Puma Biotechnology PBYI:US USD 61.39M 14.81M
Regeneron Pharmaceuticals REGN:US USD 3.92B 810.4M
Sarepta Therapeutics SRPT:US USD 871.67M 95.11M
Seattle Genetics SGEN:US USD 335.85M 15.91M
United Therapeutics UTHR:US USD 1.16B 202.3M
Vanda Pharmaceuticals VNDA:US USD 354.17M 219.14M